Tejas M. Dhameliya

In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis

Normi D. Gajjar, Tejas M. Dhameliya, Gaurang Shah · Journal of Molecular Structure · 2021 · 81 citations · Full text

Molecular Docking, Admet Analysis, Medicine +7

Benzo[ d ]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies

Sahaj Pancholia, Tejas M. Dhameliya, Parth N. Shah et al. · European Journal of Medicinal Chemistry · 2016 · 57 citations

Combinatorial Chemistry, Medicinal Chemistry, Bioorganic Chemistry +11

Synthesis, biological evaluation and structure–activity relationship of 2-styrylquinazolones as anti-tubercular agents

Pradeep S. Jadhavar, Tejas M. Dhameliya, Maulikkumar D. Vaja et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 56 citations

Structure–activity Relationship, Anti-tubercular Agents, Medicine +7

Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship

Tejas M. Dhameliya, Rishu Tiwari, Arkaprabha Banerjee et al. · European Journal of Medicinal Chemistry · 2018 · 54 citations

Medicine, New Anti-tb Chemotypes, Structure-activity Relationship +8

N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: design, new methods of synthesis and biological evaluation

Parth N. Shah, Tejas M. Dhameliya, Rohit Bansal et al. · MedChemComm · 2014 · 53 citations

Bioorganic Chemistry, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +17